Loading clinical trials...
Loading clinical trials...
A Phase 1, Single-Ascending-Dose, Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3410738 in Healthy Adult Subjects
Conditions
Interventions
LY3410738
Placebo
Locations
2
United States
Covance Clinical Research Unit
Daytona Beach, Florida, United States
Covance Clinical Research Unit
Madison, Wisconsin, United States
Start Date
February 24, 2021
Primary Completion Date
August 4, 2021
Completion Date
August 4, 2021
Last Updated
December 26, 2023
NCT06716502
NCT07310264
NCT06290258
NCT00090662
NCT07483606
NCT06342713
Lead Sponsor
Eli Lilly and Company
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions